The company’s shares of common stock were previously quoted on the OTC Markets, Pink Tier and ceased to be quoted at the close of business on August 14. Propanc Biopharma (PPCB) is offering 1M shares of common stock in conjunction with the uplisting. D. Boral Capital and Craft Capital Management are acting as the book-running managers for this offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PPCB: